[Physiopathologic observations on the treatment with antimetabolites in primary chronic polyarthritis and hepatitis].
D000429:Alcohol Oxidoreductases; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D002807:Chondroitin / Q000378:metabolism; D002908:Chronic Disease; D003094:Collagen / Q000378:metabolism; D003238:Connective Tissue / Q000187:drug effects / Q000378:metabolism; D006505:Hepatitis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002807:Chondroitin; D003094:Collagen; D000429:Alcohol Oxidoreductases
Pathophysiologische Anmerkung zur Therapie mit Antimetaboliten bei primär-chronischer Polyarthritis und Hepatitis.